Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Neurobo Pharmaceuticals Inc (NQ: NRBO )

3.810 -0.022 (-0.58%)
Streaming Delayed Price Updated: 3:55 PM EDT, Aug 7, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 9,183
Open 3.850
Bid (Size) 3.550 (1)
Ask (Size) 3.870 (3)
Prev. Close 3.832
Today's Range 3.760 - 3.930
52wk Range 2.900 - 6.750
Shares Outstanding 4,906,002
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
NeuroBo Pharmaceuticals And 2 Other Penny Stocks Insiders Are Buying
Via Benzinga
NeuroBo Pharmaceuticals Stock Slides Despite Animal Study Showing Wegvoy, Liver Fibrosis Success
NeuroBo says DA-1241 data shows improved liver fibrosis and additive hepatoprotective effects when combined with semaglutide. 
Via Benzinga

Performance

YTD
-7.34%
-7.34%
1 Month
-17.31%
-17.31%
3 Month
-3.05%
-3.05%
6 Month
-17.53%
-17.53%
1 Year
-10.16%
-10.16%

More News

Read More
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
NRBO Stock Earnings: NeuroBo Pharmaceuticals Misses EPS for Q1 2024
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
The Top 3 Stocks to Watch This Week
Via InvestorPlace
Dow Jumps 250 Points; Honeywell Issues Weak Forecast
Via Benzinga
Topics Stocks
Exposures US Equities
Why C.H. Robinson Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Stocks Rise Amid Flood Of Economic Data
Via Talk Markets
Topics Economy
Exposures Interest Rates
Crude Oil Gains 1%; ISM Manufacturing PMI Tops Expectations
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
NeuroBo Pharmaceuticals Inc. (NASDAQ: NRBO) is One of Thursday Morning’s Most Active Stocks
Via Investor Brand Network
Exposures COVID-19
Why Obesity-Drug Maker NeuroBo Stock Is Trading Higher
Via Benzinga
Exposures Product Safety
Nasdaq Surges 100 Points; US Jobless Claims Increase To 224,000
Via Benzinga
Topics Stocks
Exposures US Equities
What's Going On With Clinical-Stage Biotech Firm NeuroBo Shares Today?
Via Benzinga
Life Science Investor Forum: Presentations Now Available for Online Viewing
From Virtual Investor Conferences
Via GlobeNewswire
Life Science Investor Forum Agenda Announced for December 14th, 2023
From Virtual Investor Conferences
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Why Eton Pharmaceuticals Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
NeuroBo Pharma Says Its Weight Loss Candidate Outperforms Major Competitors in Preclinical Obesity Study
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Why LogicMark Shares Are Trading Lower By Around 25%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.